2004
DOI: 10.1038/modpathol.3800146
|View full text |Cite|
|
Sign up to set email alerts
|

Overexpression of caspase-3 in hepatocellular carcinomas

Abstract: Caspase-3 is a downstream effector cysteine protease in the apoptotic pathway. It is ubiquitously expressed in normal human tissues including the liver. Overexpression and loss of expression of caspase-3 has been reported in diverse human malignancies. However, expression of caspase-3 in hepatocellular carcinoma (HCC) has not been studied. Therefore, we studied its expression in four hepatoma cell lines and 22 HCCs by Western blot, and correlated the findings with in vitro caspase-3 activity and apoptosis. In … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
60
0
2

Year Published

2006
2006
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 94 publications
(65 citation statements)
references
References 31 publications
3
60
0
2
Order By: Relevance
“…Though caspase-3 is one of the most important molecules in the apoptosis cascade, studies of it in terms of lung cancer outcome have been limited. Several studies of caspase-3 expression have shown conflicting effects on survival [48][49][50]. Our study indicates that the total amount of caspase-3 expression was important for its function in NSCLC tissues, although the activity of the protein remains unclear.…”
mentioning
confidence: 71%
“…Though caspase-3 is one of the most important molecules in the apoptosis cascade, studies of it in terms of lung cancer outcome have been limited. Several studies of caspase-3 expression have shown conflicting effects on survival [48][49][50]. Our study indicates that the total amount of caspase-3 expression was important for its function in NSCLC tissues, although the activity of the protein remains unclear.…”
mentioning
confidence: 71%
“…Overexpression of CASP3 has also been reported in hepatocellular carcinomas. 39 Coexistence of high levels of CASP3 or CASP8 and BIRC5 or XIAP has been described in other tumor cell lines and tissues. 40 Thus, our data showed IAPs and CASP3, being functionally adversarial molecules, could be coexpressed at higher levels in urothelial carcinoma than in normal urothelium as well.…”
Section: Discussionmentioning
confidence: 98%
“…Similarly, lower expression of caspase 3 has been previously reported as present in less differentiated prostate adenocarcinomas [23] . Conversely, Persad et al [24] showed increased expression of caspase 3 in 52% of resected HCC samples, a distinguishing feature from the surrounding non-HCC tissue. The results from our study, presented herein, probably reflect a larger sample of poorly differentiated HCC with a higher proportion of caspase 3 loss.…”
Section: Discussionmentioning
confidence: 99%